Riskpilot← Back to searchSign inGet full accessArctic Biomaterials Oy
OYActiveY-tunnus 2634003-8Arvo Ylpön Katu 41Research and experimental development on natural sciences and engineering · NACE 7210Est. 201479 employees
Revenue 2024
EUR 10,4M
+14% vs 2023
EBITDA margin
7.6%
+7386% vs 2023
Equity ratio
-569.5%
Financial strength
Net profit 2024
EUR 41K
+105% vs 2023
| Revenue | EUR 10,4M | +14% |
| EBITDA | EUR 798K | +7386% |
| Net profit | EUR 41K | +105% |
| Total assets | EUR 6,1M | -3% |
| Equity | EUR -34,8M | +0% |
| Employees | 79 | — |
Legal name
Arctic Biomaterials Oy
Y-tunnus number
2634003-8
Legal form
Osakeyhtiö
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
7. elokuuta 2014
Share capital
EUR 2 500
Employees
79 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Yhtiön toimialana on biomateriaaleihin perustuvien valmisteiden ja palveluiden kehittäminen, valmistaminen, markkinointi ja myynti. Yhtiö voi omistaa kiinteistöjä, kiinteistöosakkeita, asunto-osakkeita ja arvopapereita.
Address
Arvo Ylpön Katu 41
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 625 | 0 | 4 101 | 9 165 | 10 446 |
| Staff expenses | −4 193 | −0 | −4 128 | −4 903 | −5 505 |
| EBITDA | −4 163 | 0 | −2 993 | 11 | 798 |
| Depreciation & amort. | −601 | −0 | −636 | −772 | −754 |
| EBIT | −4 764 | 0 | −3 629 | −762 | 44 |
| Net financials | −1 250 | 0 | 66 | −3 | −3 |
| Profit before tax | −6 015 | 0 | −3 564 | −765 | 41 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −6 015 | 0 | −3 564 | −765 | 41 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 8 395 | 2 021 812 | 7 430 | 6 293 | 6 114 |
| Equity | −29 134 | 4 313 | 6 050 | −34 863 | −34 822 |
| Long-term debt | 31 566 | 0 | 9 | 38 928 | 38 928 |
| Short-term debt | 5 962 | 0 | 1 371 | 2 229 | 2 009 |
| Total debt | 37 529 | 0 | 1 380 | 41 156 | 40 936 |
EBITDA margin
7.6%
This company
15.8%
Market median
-52% vs market
20202024
Equity ratio
-569.5%
This company
38.2%
Market median
-1591% vs market
20202024
Return on equity
4142000.0%
This company
18.4%
Market median
+22510770% vs market
20202024
Net profit margin
0.4%
This company
8.1%
Market median
-95% vs market
20202024
Asset turnover
1.71×
This company
1.12×
Market median
+53% vs market
20202024
Debt / equity
1.18×
This company
0.62×
Market median
-90% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MT Deputy Member | Deputy Member | 2023 |
| Former (2) | ||
PS Audit | Audit | 2014 – 2023 |
MT Deputy Member | Deputy Member | 2015 – 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2023 | |
| Chairperson | 2023 | |
| Former (1) | ||
| Board of Directors | 2015 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Arctic Biomaterials Oy 
miniFactory Oy LtdBoard members of Arctic Biomaterials Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Miika Tapani Lehtola | Deputy Member | 0 companies |
| Pekka Sakari Hietala | Audit | 0 companies |
| Mikko Tapio Huttunen | Deputy Member | 0 companies |
| Max Arne Arthur Gylling | Board of Directors | 0 companies |
| Linlin Wang | Board of Directors | 0 companies |
| Minli Zhao | Chairperson | 0 companies |